All about Teva

We are committed to providing innovative and quality medicines to the patients we serve around the world every day - supporting healthcare professionals, families and communities to improve health

Teva in the spotlight

We provide medicines that improve health and enable better days. We market generic and branded prescription medications and devices, as well as over-the-counter consumer health treatments.

Focused on your needs

Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world

Learn more Focused on your needs

Teva in the UK

Teva is a big player on the world stage - that brings considerable benefits to patients in the UK. The chances are someone you know is living a healthier life because of our medicines.

Learn more Teva in the UK

Our contribution to UK healthcare

As one of the largest suppliers of medicines to the NHS, we’re proud to improve the lives of millions of patients across the UK. We deliver savings to the NHS through our generic medicines, and we drive innovation in the life sciences industry.

Learn more Our contribution to UK healthcare

Collaborative working with the NHS

We work with NHS organisations at national, regional and local level, focussing on improving patient outcomes by implementing developments in healthcare delivery

Learn more Collaborative working with the NHS

Our history

We've been around longer than the NHS, and that's going back a long way!

Discover more Our history

Our medicines

We provide innovative and high-quality treatments for millions of people around the world
Read more

Where could you fit in at Teva?

We offer you the chance to make a real difference in people's lives
Read more

Teva worldwide

We rank among the leading pharmaceutical companies in the world and are active in 60 markets
Read more

Our impact

We're committed to making a positive impact by leading a socially responsible business
Read more

News

News, stories and updates from Teva in the UK
Read more
Date of preparation: August 2021
Reference: COB-GB-NP-00070